Singapore markets closed

SAB Biotherapeutics, Inc. (SABS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.1000-0.1800 (-4.21%)
At close: 04:00PM EDT
4.1100 +0.01 (+0.24%)
After hours: 06:39PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
16,515
16,515
36,439
57,184
27,909
Selling general and administrative
23,799
23,799
16,383
17,086
6,772
Total operating expenses
38,075
38,075
28,918
13,393
-20,557
Operating income or loss
-38,075
-38,075
-28,918
-13,393
20,557
Interest expense
315.284
315.284
301.584
294.459
469.151
Total other income/expenses net
-4,388
-4,388
10,433
-3,480
3.996
Income before tax
-42,194
-42,194
-18,715
-17,145
20,118
Income tax expense
0
0
25.629
0
-
Income from continuing operations
-42,194
-42,194
-18,741
-17,145
20,118
Net income
-42,194
-42,194
-18,741
-17,145
20,118
Net income available to common shareholders
-42,194
-42,194
-18,741
-17,145
20,118
Basic EPS
-5.60
-
-4.31
-6.30
4.63
Diluted EPS
-5.60
-
-4.31
-6.30
4.63
Basic average shares
4,956
-
4,352
2,734
4,347
Diluted average shares
4,956
-
4,352
2,734
4,347